Neodyne Biosciences is an evidence based company developing and commercializing innovative tissue repair devices to minimize scar formation, restoring both function and aesthetic appearance. Utilizing our patented technology, we believe that effective scar minimization will become a reality for many of those undergoing surgical procedures.
Our strategy is to establish our technology as a global standard of care for the prevention of scarring – initially entering the market with aesthetic and reconstructive plastic surgery solutions, and then expanding beyond plastic surgery with our technology to address various injury and non-discretionary surgical incisional wounds.
Neodyne was founded in 2007 at Stanford University. In 2008, the company was spun out of Stanford and is currently being led by an experienced team of medical device industry executives. Neodyne is located in the heart of Silicon Valley with access to a wealth of expertise in medical technology research and development and venture capital.
Company’s Keywords:
biotechnology, life sciences, medical device manufacturing
<16
<8000000
<2007